ethylene brassylate: a perfume ingredient; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 61014 |
| CHEMBL ID | 2059298 |
| CHEBI ID | 168721 |
| SCHEMBL ID | 291354 |
| MeSH ID | M0509668 |
| Synonym |
|---|
| CHEBI:168721 |
| wln: t-17-avo eovtj |
| nsc-46155 |
| ethylene undecane dicarboxylate |
| ethylene brassylate |
| tridecanedioic acid, cyclic ethylene ester |
| astratone |
| 1,17-dione |
| 1, ester with ethylene glycol |
| musk t |
| 1,4-dioxacycloheptadecane-5,17-dione |
| 105-95-3 |
| OPREA1_321002 |
| OPREA1_440108 |
| ethylene brassylate, >=95%, fg |
| ethylene glycol brassylate, cyclic diester |
| ccris 9097 |
| brn 0212344 |
| cyclo-1,13-ethylenedioxytridecan-1,13-dione |
| fema no. 3543 |
| ai3-24589 |
| ethylene glycol, cyclic tridecanedioate |
| 1,1'-undecanedicarboxylic acid, ester with ethylene glycol |
| einecs 203-347-8 |
| ethyl brassylate |
| emeressence 1150 |
| nsc 46155 |
| AKOS000623114 |
| ethylene glycol brassylate |
| brassylic acid ethylene ester |
| ethylene tridecanedioate |
| E0344 |
| NCGC00248236-01 |
| tox21_300971 |
| cas-105-95-3 |
| NCGC00254874-01 |
| dtxsid1044774 , |
| dtxcid9024774 |
| CHEMBL2059298 |
| 4-19-00-01936 (beilstein handbook reference) |
| ec 203-347-8 |
| unii-9a87hc7rod |
| 9a87hc7rod , |
| FT-0626301 |
| ethylene brassylate [inci] |
| ethylene brassylate [fcc] |
| ethylene brassylate [fhfi] |
| SCHEMBL291354 |
| astra-tone |
| ethylene 1,13-tridecanedioate |
| 1,11-undecanedicarboxylic acid, ester with ethylene glycol |
| ethylene brassylate, analytical standard |
| mfcd00046977 |
| AS-62929 |
| musk nn 10 microg/ml in cyclohexane |
| ethylene brasylate |
| 91462-25-8 |
| ethylenebrassylate |
| 1,4-dioxa-5,17-cyclo-heptadecandione |
| Q21099110 |
| STL560820 |
| CS-W010100 |
| D77704 |
| HY-W009384 |
| SY052237 |
Poly(ethylene brassylate) (PEB) is a biodegradable polyester that nowadays is of particular interest owing to its poly(ε-caprolactone)-like properties. It is a member of the structural group macrocyclic lactone and lactide derivatives.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Poly(ethylene brassylate) (PEB) is a biodegradable polyester that nowadays is of particular interest owing to its poly(ε-caprolactone)-like properties (with a Tg at -30°C and a Tm at 70°C) and the low-cost of its monomer. " | ( Effect of molecular weight on the physical properties of poly(ethylene brassylate) homopolymers. Aguirre, M; Amestoy, H; Fernández, J; Sarasua, JR; Sardon, H; Varga, AL, 2016) | 1.19 |
| "Ethylene brassylate is a member of the fragrance structural group macrocyclic lactone and lactide derivatives." | ( Fragrance material review on ethylene brassylate. Api, AM; Letizia, CS; McGinty, D, 2011) | 1.38 |
| Class | Description |
|---|---|
| macrolide | A macrocyclic lactone with a ring of twelve or more members derived from a polyketide. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| AR protein | Homo sapiens (human) | Potency | 4.4546 | 0.0002 | 21.2231 | 8,912.5098 | AID743036; AID743053 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 41.1999 | 0.0008 | 17.5051 | 59.3239 | AID1159531 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 10.9622 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 48.5577 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 14.5602 | 0.0016 | 28.0151 | 77.1139 | AID1224843; AID1224895 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 42.0291 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 54.8442 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID671793 | Increase in ceramide content in hairless mouse skin at 1% w/v administered topically after 30 hrs relative to vehicle treated control | 2012 | Bioorganic & medicinal chemistry, Jun-15, Volume: 20, Issue:12 | Improvement by sodium dl-α-tocopheryl-6-O-phosphate treatment of moisture-retaining ability in stratum corneum through increased ceramide levels. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (50.02) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (22.22%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (77.78%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||